Goeltz II Robert C. sold RCUS
May 11, 2026 · Form 4 insider transaction
Goeltz II Robert C. sold 7,763 shares of Arcus Biosciences, Inc. at $25.63 per share, a transaction worth $199.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
7,763
Price
$25.63
Total value
$199.0K
InsiderGoeltz II Robert C.
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 11, 2026
Filing dateMay 12, 2026
Shares owned after84,161
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; Includes the unvested portion of the reporting person's RSU grants.